Literature DB >> 10200495

Expression of genes that regulate Fas signalling and Fas-mediated apoptosis in colon carcinoma cells.

D M Tillman1, F G Harwood, A A Gibson, J A Houghton.   

Abstract

The expression of genes that regulate Fas-induced apoptosis has been examined in 10 human cultured colon carcinoma cell lines with defined and varied sensitivity to the cytolytic anti-Fas MoAb CH-11. Four lines demonstrated sensitivity to CH-11 (HT29, GC3/c1, TS-, Thy4), and six were resistant to the induction of apoptosis vis Fas. In nine lines expressing Fas, PCR-sequencing indicated that the death domain contained wt sequences. Downstream of Fas, expression of FADD/MORT1 and FLICE, essential components of the DISC, and negative regulators of Fas signalling including sFas, FAP-1 and Bcl-2, showed no correlation between levels of expression and sensitivity to Fas-mediated cytotoxicity. However, levels of the Fas antigen varied by >1000-fold, and correlated with CH-11 sensitivity. Following fourfold elevation in Fas expression in HT29 cells treated with interferon-gamma, a synergistic effect on Fas-mediated apoptosis was obtained when CH-11 and interferon-gamma were combined.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10200495     DOI: 10.1038/sj.cdd.4400369

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  9 in total

Review 1.  Targeting cell death signaling in colorectal cancer: current strategies and future perspectives.

Authors:  Bruno Christian Koehler; Dirk Jäger; Henning Schulze-Bergkamen
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 2.  PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Authors:  Gilles Freiss; Dany Chalbos
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

3.  Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin.

Authors:  Tanvi S Jani; Jennifer DeVecchio; Tapati Mazumdar; Akwasi Agyeman; Janet A Houghton
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

4.  Increased expression but not sensitivity to Fas/CD95 in glioblastoma cells depleted of mitochondrial DNA.

Authors:  Bertrand C Liang
Journal:  Exp Ther Med       Date:  2010-09-29       Impact factor: 2.447

Review 5.  PTPL1: a large phosphatase with a split personality.

Authors:  Ogan D Abaan; Jeffrey A Toretsky
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

6.  Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.

Authors:  H Yao; E Song; J Chen; P Hamar
Journal:  Br J Cancer       Date:  2004-11-01       Impact factor: 7.640

7.  Kupffer cells of cirrhotic rat livers sensitize colon cancer cells to Fas-mediated apoptosis.

Authors:  E Song; J Chen; N Ouyang; M Wang; M S Exton; U Heemann
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

8.  Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status.

Authors:  R A Bras-Gonçalves; C Rosty; P Laurent-Puig; P Soulié; B Dutrillaux; M F Poupon
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

9.  Inhibition of Fas associated phosphatase 1 (Fap1) facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatin.

Authors:  Weiqi Huang; Ling Bei; Elizabeth A Eklund
Journal:  Oncotarget       Date:  2018-05-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.